BlackRock-advised Funds > iShares Trust
iShares Global Healthcare ETF
Exchange-Traded Fund
Index Fund
Master-Feeder Fund
Series ID: S000004372
LEI: 5493008DMA8OZ7F0WV53
SEC CIK: 1100663
$4.02B
Avg Monthly Net Assets
$4.03B
Total Assets
$24.55M
Total Liabilities
$4.01B
Net Assets
iShares Global Healthcare ETF is an Exchange-Traded Fund in iShares Trust
from BlackRock-advised Funds,
based in California,
United States of America.
The fund has one share class
and monthly net assets of $4.02B.
On August 26th, 2024 it reported 115 holdings, the largest
being Eli Lilly & Co (9.6%), UnitedHealth Group Inc (6.2%) and Novo Nordisk A/S (6.0%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| iShares Global Healthcare ETF | C000012102 | ARCX | IXJ |
Holdings
From latest NPORT-P, filed August 26th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $96M | 922K | 2.39 |
| AbbVie Inc | Long | Equity-common | US | $160M | 936K | 4.01 |
| Agilent Technologies Inc | Long | Equity-common | US | $20M | 155K | 0.50 |
| Alcon Inc | Long | Equity-common | CH | $23M | 263K | 0.58 |
| Align Technology Inc | Long | Equity-common | US | $9M | 38K | 0.23 |
| Amgen Inc | Long | Equity-common | US | $89M | 284K | 2.22 |
| Argenx SE | Long | Equity-common | NL | $14M | 31K | 0.34 |
| Astellas Pharma Inc | Long | Equity-common | JP | $9M | 956K | 0.24 |
| AstraZeneca PLC | Long | Equity-common | GB | $128M | 822K | 3.19 |
| Baxter International Inc | Long | Equity-common | US | $9M | 270K | 0.23 |
| Bayer AG | Long | Equity-common | DE | $15M | 519K | 0.36 |
| Becton Dickinson & Co | Long | Equity-common | US | $36M | 153K | 0.89 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $3M | 10K | 0.07 |
| Bio-Techne Corp | Long | Equity-common | US | $6M | 84K | 0.15 |
| Biogen Inc | Long | Equity-common | US | $18M | 77K | 0.45 |
| BlackRock Cash Funds: Institutional, SL Agency Shares (BlackRock Funds III) | Long | Short-term investment vehicle | US | $11M | 11M | 0.29 |
| BlackRock Cash Funds: Treasury, SL Agency Shares (BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES) | Long | Short-term investment vehicle | US | $9M | 9M | 0.22 |
| Boston Scientific Corp | Long | Equity-common | US | $60M | 778K | 1.50 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $45M | 1M | 1.12 |
| Cardinal Health Inc | Long | Equity-common | US | $13M | 129K | 0.32 |
| Catalent Inc | Long | Equity-common | US | $5M | 95K | 0.13 |
| Celltrion Inc | Long | Equity-common | KR | $11M | 84K | 0.26 |
| Cencora Inc | Long | Equity-common | US | $20M | 88K | 0.49 |
| Centene Corp | Long | Equity-common | US | $19M | 283K | 0.47 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $6M | 27K | 0.14 |
| Chugai Pharmaceutical Co Ltd | Long | Equity-common | JP | $12M | 341K | 0.30 |
| Cigna Group/The | Long | Equity-common | US | $50M | 151K | 1.24 |
| Cochlear Ltd | Long | Equity-common | AU | $8M | 34K | 0.19 |
| Coloplast A/S | Long | Equity-common | DK | $8M | 65K | 0.20 |
| Cooper Cos Inc/The | Long | Equity-common | US | $9M | 105K | 0.23 |
| CSL Ltd | Long | Equity-common | AU | $50M | 256K | 1.25 |
| CVS Health Corp | Long | Equity-common | US | $39M | 665K | 0.98 |
| Daiichi Sankyo Co Ltd | Long | Equity-common | JP | $36M | 1M | 0.89 |
| Danaher Corp | Long | Equity-common | US | $87M | 349K | 2.18 |
| DaVita Inc | Long | Equity-common | US | $4M | 29K | 0.10 |
| Dexcom Inc | Long | Equity-common | US | $24M | 211K | 0.60 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $29M | 319K | 0.74 |
| Eisai Co Ltd | Long | Equity-common | JP | $6M | 157K | 0.16 |
| Elevance Health Inc | Long | Equity-common | US | $67M | 123K | 1.66 |
| Eli Lilly & Co | Long | Equity-common | US | $383M | 423K | 9.56 |
| EssilorLuxottica SA | Long | Equity-common | FR | $33M | 151K | 0.81 |
| Eurofins Scientific SE | Long | Equity-common | LU | $3M | 68K | 0.09 |
| Fresenius Medical Care AG | Long | Equity-common | DE | $4M | 106K | 0.10 |
| Fresenius SE & Co KGaA | Long | Equity-common | DE | $6M | 216K | 0.16 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $18M | 225K | 0.44 |
| Genmab A/S | Long | Equity-common | DK | $9M | 35K | 0.22 |
| Getinge AB | Long | Equity-common | SE | $2M | 122K | 0.05 |
| Gilead Sciences Inc | Long | Equity-common | US | $45M | 660K | 1.13 |
| Grifols SA | Long | Equity-common | ES | $1M | 154K | 0.03 |
| GSK PLC | Long | Equity-common | GB | $42M | 2M | 1.04 |
| HCA Healthcare Inc | Long | Equity-common | US | $33M | 103K | 0.82 |
| Henry Schein Inc | Long | Equity-common | US | $4M | 68K | 0.11 |
| Hologic Inc | Long | Equity-common | US | $9M | 124K | 0.23 |
| Hoya Corp | Long | Equity-common | JP | $22M | 185K | 0.54 |
| Humana Inc | Long | Equity-common | US | $24M | 64K | 0.60 |
| IDEXX Laboratories Inc | Long | Equity-common | US | $21M | 44K | 0.53 |
| Incyte Corp | Long | Equity-common | US | $6M | 98K | 0.15 |
| Insulet Corp | Long | Equity-common | US | $7M | 37K | 0.19 |
| Intuitive Surgical Inc | Long | Equity-common | US | $84M | 188K | 2.09 |
| IQVIA Holdings Inc | Long | Equity-common | US | $20M | 96K | 0.51 |
| Johnson & Johnson | Long | Equity-common | US | $183M | 1M | 4.57 |
| Koninklijke Philips NV | Long | Equity-common | NL | $13M | 499K | 0.31 |
| Labcorp Holdings Inc | Long | Equity-common | US | $9M | 45K | 0.23 |
| Lonza Group AG | Long | Equity-common | CH | $21M | 39K | 0.54 |
| M3 Inc | Long | Equity-common | JP | $2M | 226K | 0.05 |
| McKesson Corp | Long | Equity-common | US | $40M | 69K | 1.00 |
| Medtronic PLC | Long | Equity-common | IE | $55M | 703K | 1.38 |
| Merck & Co Inc | Long | Equity-common | US | $166M | 1M | 4.15 |
| Merck KGaA | Long | Equity-common | DE | $11M | 68K | 0.28 |
| Mettler-Toledo International Inc | Long | Equity-common | US | $16M | 11K | 0.40 |
| Moderna Inc | Long | Equity-common | US | $21M | 177K | 0.52 |
| Molina Healthcare Inc | Long | Equity-common | US | $9M | 31K | 0.23 |
| Novartis AG | Long | Equity-common | CH | $113M | 1M | 2.81 |
| Novo Nordisk A/S | Long | Equity-common | DK | $242M | 2M | 6.03 |
| Olympus Corp | Long | Equity-common | JP | $10M | 623K | 0.25 |
| Ono Pharmaceutical Co Ltd | Long | Equity-common | JP | $4M | 258K | 0.09 |
| Otsuka Holdings Co Ltd | Long | Equity-common | JP | $12M | 295K | 0.31 |
| Pfizer Inc | Long | Equity-common | US | $84M | 3M | 2.10 |
| QIAGEN NV | Long | Equity-common | NL | $5M | 116K | 0.12 |
| Quest Diagnostics Inc | Long | Equity-common | US | $8M | 59K | 0.20 |
| Ramsay Health Care Ltd | Long | Equity-common | AU | $3M | 98K | 0.08 |
| Rede D'Or Sao Luiz SA | Long | Equity-common | BR | $3M | 542K | 0.07 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $59M | 56K | 1.47 |
| ResMed Inc | Long | Equity-common | US | $15M | 78K | 0.37 |
| Revvity Inc | Long | Equity-common | US | $7M | 65K | 0.17 |
| Roche Holding AG | Long | Equity-common | CH | $103M | 373K | 2.58 |
| Roche Holding AG | Long | Equity-common | CH | $4M | 14K | 0.11 |
| Sandoz Group AG | Long | Equity-common | CH | $8M | 229K | 0.21 |
| Sanofi SA | Long | Equity-common | FR | $57M | 591K | 1.42 |
| Sartorius AG | Long | Equity-preferred | DE | $3M | 15K | 0.09 |
| Sartorius Stedim Biotech | Long | Equity-common | FR | $2M | 15K | 0.06 |
| Shionogi & Co Ltd | Long | Equity-common | JP | $6M | 148K | 0.14 |
| Siemens Healthineers AG | Long | Equity-common | DE | $9M | 150K | 0.22 |
| Smith & Nephew PLC | Long | Equity-common | GB | $6M | 462K | 0.14 |
| Solventum Corp | Long | Equity-common | US | $4M | 73K | 0.10 |
| Sonic Healthcare Ltd | Long | Equity-common | AU | $4M | 255K | 0.11 |
| Sonova Holding AG | Long | Equity-common | CH | $8M | 25K | 0.19 |
| STERIS PLC | Long | Equity-common | IE | $12M | 52K | 0.29 |
| Straumann Holding AG | Long | Equity-common | CH | $8M | 62K | 0.19 |
| Stryker Corp | Long | Equity-common | US | $61M | 179K | 1.52 |
| Sysmex Corp | Long | Equity-common | JP | $4M | 252K | 0.10 |
| Takeda Pharmaceutical Co Ltd | Long | Equity-common | JP | $22M | 838K | 0.54 |
| Teleflex Inc | Long | Equity-common | US | $5M | 25K | 0.13 |
| Terumo Corp | Long | Equity-common | JP | $13M | 788K | 0.33 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $112M | 202K | 2.79 |
| UCB SA | Long | Equity-common | BE | $9M | 63K | 0.23 |
| UnitedHealth Group Inc | Long | Equity-common | US | $248M | 487K | 6.19 |
| Universal Health Services Inc | Long | Equity-common | US | $6M | 32K | 0.15 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $64M | 137K | 1.60 |
| Viatris Inc | Long | Equity-common | US | $7M | 633K | 0.17 |
| Waters Corp | Long | Equity-common | US | $9M | 31K | 0.23 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $13M | 39K | 0.32 |
| XAV HEALTH CARE SEP24 (Chicago Mercantile Exchange) | Derivative-equity | US | $64K | – | 0.00 | |
| Zimmer Biomet Holdings Inc | Long | Equity-common | US | $12M | 109K | 0.30 |
| Zoetis Inc | Long | Equity-common | US | $42M | 242K | 1.05 |
Address
iShares Trust
400 Howard Street
San Francisco
California
94105
United States of America
Websites
Directors
John E. Kerrigan
Richard L. Fagnani
Robert S. Kapito
Drew E. Lawton
Stephen Cohen
John E. Martinez
Madhav V. Rajan
Jane D. Carlin
Cecilia H. Herbert
Transfer Agents
Citibank, N.A.
Pricing Services
Refinitiv US Holdings Inc.
ICE Data Services, Inc.
Bloomberg L.P.
Custodians
Citibank, N.A.
SG Americas Securities, LLC
Shareholder Servicing Agents
N/A
Admins
Citi Fund Services Ohio, Inc.
Brokers
Barclays Capital Inc.
Morgan Stanley & Co. LLC
Jefferies LLC
J.P. Morgan Securities LLC
UBS Securities LLC
BNP Paribas Securities Corp.
Goldman Sachs & Co. LLC
Merrill Lynch, Pierce, Fenner & Smith Incorporated
CASTLE OAK SECURITIES, L.P.
Instinet, LLC